Where others see data,
we see answers

Our global data-sharing network generates clinically actionable insights from data to improve patient outcomes worldwide.

SOPHiA GENETICS Homepage Banner 5

Where others see data,
we see answers

Our global data-sharing network generates clinically actionable insights from data to improve patient outcomes worldwide.

pink dots icon

Democratizing data-driven medicine, together.

SOPHiA GENETICS’ mission is to build the future of AI-assisted medicine. We are integrating multimodal healthcare-omics data, unlocking the existing data silos and developing machine learning models to produce actionable insights that could eventually support healthcare professionals to improve patient outcomes.

OUR CUSTOMER BASE

750+

Healthcare Institutions

OUR GLOBAL FOOTPRINT

70+

Countries

GENOMIC PROFILES

1 Million+

Genomic Profiles Analyzed

OUR CUSTOMER BASE

750+

Healthcare Institutions

OUR GLOBAL FOOTPRINT

70+

Countries

GENOMIC PROFILES

1 Million+

Genomic Profiles Analyzed

Retain ownership of your data.

SOPHiA DDM™: A universal healthcare analytics platform

Powered by AI and machine learning (ML), our global cloud-based platform provides a safe, secure, and instantly accessible environment to standardize, compute, and analyze digital health data, generating insights from complex multimodal data sets that have the potential to improve diagnosis, therapy selection, analysis, and drug development. Our customers perform testing on their own samples, retain custody of both their samples and data, and use the SOPHiA DDM platform to analyze data and share insights with each other to grow a collective intelligence.

The SOPHiA DDM platform provides analysis and insights across multiple disease areas – from oncology to inherited disorders – and is designed to continually improve as we analyze more data over time.

A universal health data analytics platform for a decentralized approach to healthcare

Expand identification of HRD positive ovarian cancers.

SOPHiA DDM HRD Solution combines information from germline and somatic HRR mutations (including BRCA1 and BRCA2) with a measure of genomic scarring.

Build in-house expertise on HRD testing with a decentralized workflow, retaining ownership of all data.

Latest News & Events

';